Elizabeth M.
Elizabeth M. Berry-Kravis, Des Plaines, IL US
Patent application number | Description | Published |
---|---|---|
20080286794 | METHODS AND PRIMERS FOR DIAGNOSING IDIOPATHIC CONGENITAL CENTRAL HYPOVENTILATION SYNDROME - The present invention provides assays and kits for diagnosing idiopathic congenital central hypoventilation syndrome. The present assays and kits focus on the second polyalanine repeat of the PHOX2b gene or gene product, which is normally 20 residues in length. A polyalanine repeat 25 to 33 residues in length is strongly correlated with idiopathic congenital central hypoventilation syndrome. | 11-20-2008 |
20090291451 | METHODS AND PRIMERS FOR DIAGNOSING IDIOPATHIC CONGENITAL CENTRAL HYPOVENTILATION SYNDROME - The present invention provides assays and kits for diagnosing idiopathic congenital central hypoventilation syndrome. The present assays and kits focus on the second polyalanine repeat of the PHOX2b gene or gene product, which is normally 20 residues in length. A polyalanine repeat 25 to 33 residues in length is strongly correlated with idiopathic congenital central hypoventilation syndrome. | 11-26-2009 |
Elizabeth M. Bowman, Madison, AL US
Patent application number | Description | Published |
---|---|---|
20160069824 | Nonaqueous Radiopaque Fluid and Associated Imaging System and Method - An imaging system including an imaging device having a field of view, an object positioned in the field of view, the object defining a void, and a nonaqueous radiopaque fluid in the void. | 03-10-2016 |
Elizabeth M. Brown, Bloomington UD
Patent application number | Description | Published |
---|---|---|
20150306329 | PRESSURE OR FLOW LIMITING ADAPTOR - An adapter for use in airway exchange procedure capable of being rapidly coupled and uncoupled to the catheter and being capable of regulating the flow of fluid delivered to the trachea of the patient. Oxygenation is received at the proximal end of the adapter and delivered to a catheter at the distal end. The adapter may include a relief valve to release excess fluid from the provided oxygenation. The adapter may also include a throttling valve to limit the flow of fluid within the valve, preventing excessive pressure or flow rate of breathable fluid to the catheter. During the procedure, the adapter and oxygenation source may be rapidly uncoupled and coupled to the catheter by a connector on the distal end of the adapter. | 10-29-2015 |
Elizabeth M. Brown, Pierre, SD US
Patent application number | Description | Published |
---|---|---|
20120040335 | Identification of Porcine Reproductive and Respiratory Syndrome Virus - An enzyme-linked immunosorbent assay (ELISA) is based on the non-structural protein 7 (nsp7) of porcine reproductive and respiratory syndrome virus (PRRSV) and provides for the simultaneous detection and differentiation of serum antibodies directed against Type 1 (European) and Type 2 (North American) PRRSV. The invention provides a serological assay for the detection and/or differentiation of serum antibodies directed against Type 1 and/or Type 2 PRRSV utilizing PRRSV nsp7 as an antigen, and provides a diagnostic method for the detection of PRRSV infection, epidemiological surveys, and outbreak investigations. The invention may be used either alone or as a follow-up assay to determine the true status of unexpected positive results that may occur using other assays, such as the IDEXX HERDCHEK PRRS ELISA. | 02-16-2012 |
Elizabeth M. Cosgriff-Hernandez, College Station, TX US
Patent application number | Description | Published |
---|---|---|
20110288274 | Designer collagens and use thereof - The present invention identified a recombinant synthetic collagen containing a triple helical backbone protein produced in a prokaryotic expression system where the protein contains at least one ‘inserted’ biologically active sequence(s). | 11-24-2011 |
20130287735 | HIGH POROSITY MATERIALS, SCAFFOLDS, AND METHOD OF MAKING - Materials and methods for preparing three dimensional scaffolds are described. The materials, as improved high internal phase emulsions (HIPES), and the polymerization thereof may be suitable for injection prior to curing and when in an injectable form may be for site-directed in vivo use, curing after injection. In addition, said materials before curing may be engineered as a tissue substitution or enhancement and/or to include cell encapsulation. Said materials described herein form a monolith after curing and are biodegradable and porous after curing. Said materials are made from starting molecules using a process that does not rely on toxic solvents or monomers. Making of said materials to form the emulsion take advantage of one or more surfactants for HIPE stability. In addition, said materials cure at temperatures appropriate for use in an in vivo or in situ environment. | 10-31-2013 |
20140163205 | DESIGNER COLLAGENS AND USE THEREOF - The present disclosure provides synthetic collagen and methods of making and using synthetic collagen that include a synthetic collagen that facilitates wound closure comprising an isolated and purified triple helical backbone protein that facilitates wound closure comprising one or more alteration in a triple helical backbone protein sequence, that stabilize the isolated and purified triple helical backbone protein and does not disrupt an additional collagen ligand interaction; and one or more integrin binding motifs, wherein the isolated and purified triple helical backbone protein facilitates wound closure. | 06-12-2014 |
Elizabeth M. Foran-Owens, Stamford, CT US
Patent application number | Description | Published |
---|---|---|
20110047036 | ALL-IN-ONE PROXIMITY PAYMENT DEVICE WITH LOCAL AUTHENTICATION - A personal powered proximity payment device that can be owned by or issued to an individual user is provided. The device is a non-ISO card device that includes an internal dual-mode (contact and contactless) chip card coupled to a display and a robust PIN entry or biometric reading means. The device provides proximity payment functions, and optional proximity payment on/off and local pre-purchase account holder verification functions to the individual user. | 02-24-2011 |
Elizabeth M. Gadwa, Greenfield, MA US
Patent application number | Description | Published |
---|---|---|
20150310476 | System and method for attention based currency - A system and method is disclosed of attention based cryptocurrency. Currency is generated or “mined” by a user listening, in one embodiment, to a streamed song, and upon listening to the entire selection, the user, the song artist and the streaming host server are each allocated a portion of Attention Based Currency (ABC) according to a formula which may vary based upon several factors, including the popularity of the selection, the number of simultaneous listeners and the number of times the song has been streamed. The formula chosen can promote listening to lesser known artists. The ABC can be traded or redeemed for products or services. | 10-29-2015 |
Elizabeth M. Gendel, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20100099169 | GENETIC SELECTION SYSTEM FOR IMPROVING RECOMBINANT PROTEIN EXPRESSION - A method for selecting host cells with an improved ability to recombinantly overexpress a target protein; the host cells thus generated and their use. The invention also provides a curing method to remove plasmids from host cell lines. | 04-22-2010 |
Elizabeth M. Goslow, Encino, CA US
Patent application number | Description | Published |
---|---|---|
20100216141 | COMPOSITIONS AND METHODS TO DETECT LEGIONELLA PNEUMOPHILA NUCLEIC ACID - Compositions are disclosed as nucleic acid sequences that may be used as amplification oligomers, including primers, capture probes for sample preparation, and detection probes specific for | 08-26-2010 |
Elizabeth M. Hadac, Oronoco, MN US
Patent application number | Description | Published |
---|---|---|
20100111873 | TREATING CANCER WITH VIRAL NUCLEIC ACID - This document provides methods and materials related to the use of nucleic acid coding for viruses to reduce the number of viable cancer cells within a mammal. For example, methods for using infectious nucleic acid to treat cancer, engineered viral nucleic acid, methods for making engineered viral nucleic acid, methods for identifying infectious nucleic acid for treating cancer, methods and materials for controlling virus-mediated cell lysis, and methods and materials for assessing the control of virus-mediated cell lysis are provided. | 05-06-2010 |
20130345414 | TREATING CANCER WITH VIRAL NUCLEIC ACID - This document provides methods and materials related to the use of nucleic acid coding for viruses to reduce the number of viable cancer cells within a mammal. For example, methods for using infectious nucleic acid to treat cancer, engineered viral nucleic acid, methods for making engineered viral nucleic acid, methods for identifying infectious nucleic acid for treating cancer, methods and materials for controlling virus-mediated cell lysis, and methods and materials for assessing the control of virus-mediated cell lysis are provided. | 12-26-2013 |
20150299271 | TREATING CANCER WITH VIRAL NUCLEIC ACID - This document provides methods and materials related to the use of nucleic acid coding for viruses to reduce the number of viable cancer cells within a mammal. For example, methods for using infectious nucleic acid to treat cancer, engineered viral nucleic acid, methods for making engineered viral nucleic acid, methods for identifying infectious nucleic acid for treating cancer, methods and materials for controlling virus-mediated cell lysis, and methods and materials for assessing the control of virus-mediated cell lysis are provided. | 10-22-2015 |
Elizabeth M. Mandel-Bausch, Milford, CT US
Patent application number | Description | Published |
---|---|---|
20120189633 | ANTI-KIT ANTIBODIES AND USES THEREOF - Provided herein, in one aspect, are antibodies that immunospecifically bind to a human KIT antigen comprising the fourth and/or fifth extracellular Ig-like domains (that is, D4 and/or D5 domains), polynucleotides comprising nucleotide sequences encoding such antibodies, and expression vectors and host cells for producing such antibodies. The antibodies can inhibit KIT activity, such as ligand-induced receptor phosphorylation. Also provided herein are kits and pharmaceutical compositions comprising antibodies that specifically bind to a KIT antigen, as well as methods of treating or managing a KIT-mediated disorder or disease and methods of diagnosing a KIT-mediated disorder or disease using the antibodies described herein. | 07-26-2012 |
20140056905 | ANTI-KIT ANTIBODIES AND USES THEREOF - Provided herein, in one aspect, are antibodies that immunospecifically bind to a human KIT antigen comprising the fourth and/or fifth extracellular Ig-like domains (that is, D4 and/or D5 domains), polynucleotides comprising nucleotide sequences encoding such antibodies, and expression vectors and host cells for producing such antibodies. The antibodies can inhibit KIT activity, such as ligand-induced receptor phosphorylation. Also provided herein are kits and pharmaceutical compositions comprising antibodies that specifically bind to a KIT antigen, as well as methods of treating or managing a KIT-mediated disorder or disease and methods of diagnosing a KIT-mediated disorder or disease using the antibodies described herein. | 02-27-2014 |
20140065168 | ANTI-KIT ANTIBODIES AND USES THEREOF - Provided herein, in one aspect, are antibodies that immunospecifically bind to a human KIT antigen comprising the fourth and/or fifth extracellular Ig-like domains (that is, D4 and/or D5 domains), polynucleotides comprising nucleotide sequences encoding such antibodies, and expression vectors and host cells for producing such antibodies. The antibodies can inhibit KIT activity, such as ligand-induced receptor phosphorylation. Also provided herein are kits and pharmaceutical compositions comprising antibodies that specifically bind to a KIT antigen, as well as methods of treating or managing a KIT-associated disorder or disease and methods of diagnosing a KIT-associated disorder or disease using the antibodies described herein. | 03-06-2014 |
Elizabeth M. Pillarl, Tinton Falls, NJ US
Patent application number | Description | Published |
---|---|---|
20080250567 | Breast and bottle feeding infant head support - A breast and bottle feeding infant head support including a slip-on sleeve open at opposite ends and inclusive of inner and outer linings forming first and second outwardly opposing face surfaces of predetermined length and width, and a cushion insert between the inner and outer linings forming at least one of the outwardly opposing face surfaces wherein the sleeve, when worn on the arm, is of a length to extend past the crook of a wearer's elbow and towards the palm of the wearer's hand for the fingers to hold the sleeve in place. | 10-16-2008 |
Elizabeth M. Smith US
Patent application number | Description | Published |
---|---|---|
20100292203 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I | 11-18-2010 |
Elizabeth M. Toeniskoetter, Denver, CO US
Patent application number | Description | Published |
---|---|---|
20090240619 | MULTI-NATIONAL GIFT CARD SETTLEMENT - Systems and methods for settling stored value account transactions between merchants in countries that use different currencies. A host computer system receives transaction data resulting from a number of stored value account transactions performed at a number of merchants. The merchants are grouped into separate entities with separate accounting systems, and at least one entity operates in a different country than another entity. The transactions include any combination of origination transactions, redemption transactions, and reload transactions, and the transaction data includes for each redemption and reload transaction a transaction amount, locations in which the transaction occurred and the account was originated and the base currency of the account and the currency in which the transaction is performed. Periodically, accounts are settled between the entities in each country using a central country bank account in each country, and periodically accounts are settled between pairs of central country bank accounts. | 09-24-2009 |
Elizabeth M. Windram, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20130297591 | Processing the Results of Multiple Search Queries in a Mapping Application - In general, the subject matter described in this specification can be embodied in methods, systems, and program products. Information that is responsive to each of multiple distinct search queries is received from a server system. The information for each of the search queries identifies a geographical context or includes search results. One or more visual indications of the information for each of the search queries are displayed on a geographical map. A user interface element for each of the search queries is displayed. The user interface element for each of the search queries, when selected by a user, causes removal from the display of the one or more visual indications of the information for the search query that corresponds to the selected user interface element. | 11-07-2013 |
20150220538 | Processing the Results of Multiple Search Queries in a Mapping Application - A response to a first query related to a geographic area, and search results responsive to a second query related to the geographic area, are received from a server system. A digital map of the geographic is provided via a user interface. A focus is provided to the first query to illustrate the response on the digital map, where the response defines a geographic context. A subset of the search results is identified based on a relationship to the geographic context. The search results in the identified subset are visually emphasized on the digital map relative to the rest of the search results. | 08-06-2015 |
Elizabeth M. Wyrwich, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20130016024 | WIDEBAND ANTENNA SYSTEM WITH MULTIPLE ANTENNAS AND AT LEAST ONE PARASITIC ELEMENTAANM Shi; GuiningAACI San DiegoAAST CAAACO USAAGP Shi; Guining San Diego CA USAANM Tran; Allen Minh-TrietAACI San DiegoAAST CAAACO USAAGP Tran; Allen Minh-Triet San Diego CA USAANM Wyrwich; Elizabeth M.AACI San DiegoAAST CAAACO USAAGP Wyrwich; Elizabeth M. San Diego CA US - A wideband antenna system with multiple antennas and at least one parasitic element is disclosed. In an exemplary design, an apparatus includes a first antenna, a second antenna, and a parasitic element. The first antenna has a shape of an open-ended loop with two ends that overlap and are separated by a gap. The second antenna may also have a shape of an open-ended loop with two ends that overlap and are separated by a gap. The parasitic element is located between the first and second antennas. The first and second antennas may be placed side by side on a board, located at either the top end or the bottom end of a wireless device, and/or formed on opposite sides (e.g., the front and back sides) of the board. The parasitic element may be formed on a plane that is perpendicular to the plane on which the first and second antennas are formed. | 01-17-2013 |